Filing Details
- Accession Number:
- 0000950170-24-029324
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 16:30:18
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-11 16:30:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1801395 | Paul Blanchfield | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Building Bedford MA 01730 | President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-07 | 18,023 | $61.96 | 103,357 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-07 | 500 | $0.00 | 102,857 | No | 4 | G | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | G | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2023.